COMMUNIQUÉS West-GlobeNewswire

Precision Therapeutics Investee, Helomics Corporation, Announces Commercial Launch of New ‘HelomicsDiscover’ Program to Drive Forward the Next Generation of Precision Cancer Therapies

14/08/2018 - 14:00

MINNEAPOLIS, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery [...]

Inovio Announces First Patient Dosed in Trial to Determine PENNVAX®-GP’s Ability to Induce Remission of HIV Infection

14/08/2018 - 14:00

HIV Trial Will Be Fully Funded by $6.9 Million National Institutes of Health Grant PLYMOUTH MEETING, Pa., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today that the first [...]

Genacol Canada Corporation and Tetra Bio-Pharma Team Up to bring Innovative Cannabinoid Treatments to Self-Care Market in Canada

14/08/2018 - 14:00

ORLEANS, Ontario, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), is pleased to announce that they have concluded [...]

Genacol Canada Corporation et Tetra Bio-Pharma s'associent pour introduire des traitements innovants aux cannabinoïdes dans le marché des soins auto-administrés au Canada

14/08/2018 - 14:00

ORLEANS, Ontario, 14 août 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., un chef de file dans la découverte et le développement de médicaments à base de cannabinoïdes (TSX VENTURE: TBP) (OTCQB: TBPMF), est heureuse d’ [...]

Imagin Medical Reports Fiscal 2018 Third Quarter Results

14/08/2018 - 14:00

VANCOUVER, B.C. and BOSTON, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Imagin Medical (CSE:IME) (OTCQB:IMEXF) (Frankfurt:DPD2) (Stuttgart:DPD2) (“Imagin” or the “Company”) today reported financial results for the three months [...]

Cue Biopharma to Host Investor Business Update Call and Webcast

14/08/2018 - 14:00

Update on progress of selective immune modulation platform CAMBRIDGE, Mass., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc., (NASDAQ: CUE) an innovative immunotherapy company developing a novel, proprietary [...]

Onconova Therapeutics Reports Business Highlights and Financial Results for Second Quarter 2018

14/08/2018 - 14:00

NEWTOWN, Pa., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) , a Phase 3 stage biopharmaceutical company focused on developing rigosertib, a novel small molecule drug candidate to treat [...]

CymaBay Therapeutics to Participate in Upcoming Investor Conferences in August and September

14/08/2018 - 14:00

NEWARK, Calif., Aug. 14, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (Nasdaq: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]

scPharmaceuticals Inc. Reports Second Quarter 2018 Financial Results and Provides Business Update

14/08/2018 - 14:00

Request for Type A meeting was granted by the U.S. Food and Drug Administration to discuss the Complete Response Letter received in June 2018 Balance sheet remains strong with over $100 million in cash BURLINGTON, Mass [...]

CLS Holdings USA Issues Chairman’s Update

14/08/2018 - 14:00

Seeking Expansion Beyond Nevada Exploring to License the Proprietary Extraction and Conversion Processing LAS VEGAS, Aug. 14, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB: CLSH) “CLS,” a diversified cannabis [...]

Chiesi Foundation Onlus Issues 2018 Call for Scientific Research Proposals

14/08/2018 - 14:00

Scientists and researchers are invited to submit proposals for Research in neonatology and pulmonology CARY, N.C., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Chiesi Foundation Onlus (key-A-zee) announced its 2018 Call for [...]

AIT Therapeutics Reports Financial Results for First Fiscal Quarter 2019

14/08/2018 - 14:00

Started commercial development of ventilator compatible NO generator and delivery system -- FDA 510(k) submission expected in the first quarter of calendar 2019 Human and in-vitro Nitric Oxide (NO) data presented at the [...]

Progressive Care Inc. Reports Largest Six-Month Revenue Period in Company History in Q2 2018 Financial Filing

14/08/2018 - 14:00

MIAMI, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced financial results for the quarter ending June 30, 2018, and [...]

Kane Biotech Achieves DTC Eligibility in the United States

14/08/2018 - 14:00

WINNIPEG, Manitoba, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) is pleased to announce that the Corporation has secured eligibility by The [...]

CrownBio Expands Genetically Engineered Model Selection Via Strategic Alliance with Shanghai Model Organisms Center (SMOC)

14/08/2018 - 14:00

Alliance enables researchers to access thousands of GEMMs SAN DIEGO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to [...]

Micron Solutions, Inc. Reports 2018 Second Quarter Results

14/08/2018 - 13:52

FITCHBURG, Mass., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Micron Solutions, Inc. (NYSE American:MICR) (the “Company”), a diversified contract manufacturing organization, through its wholly-owned subsidiary, Micron Products, [...]

Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study

14/08/2018 - 13:48

NORTHVALE, N.J., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, [...]

Avenue Therapeutics Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights

14/08/2018 - 13:30

Company reported positive Phase 3 data in patients with post-surgical pain following bunionectomy Initiation of second pivotal Phase 3 trial expected in the second half of 2018 NEW YORK, Aug. 14, 2018 (GLOBE NEWSWIRE [...]

Iterum Reports Second Quarter 2018 Financial Results and Recent Highlights

14/08/2018 - 13:30

DUBLIN, Ireland and CHICAGO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company developing anti-infectives against multi-drug resistant pathogens, today [...]